MedTrace Logo

Management of Prostate Cancer in Central China

NCT01614548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 789

Last updated 2012-06-08

No results posted yet for this study

Summary

Some recent reports indicate that incidence of prostate cancer is increasing rapidly in China. However, no large-scale survey of prostate cancer has been done in central China, few data are available regarding its management. The investigators aimed to analyze the management of prostate cancer and compare the outcome of patients with such a survey.

The investigators collected data of patients diagnosed with prostate cancer from the 2003 and 2008 in central China. Data were disaggregated by rural and urban hukou. The survival rate of patients was analyzed using Kaplan-Meier method. Prognostic factors were analyzed using the log-rank test and Cox proportional hazards model.

Conditions

Sponsors & Collaborators

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • the cancer hospital of Zhengzhou University

    collaborator UNKNOWN

  • Third Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • People's Hospital of Zhengzhou University

    collaborator OTHER

  • Xinyang Central Hospital

    collaborator OTHER

  • Zhoukou Central Hospital

    collaborator OTHER

  • Center hospital of Nanyang

    collaborator UNKNOWN

  • Center hospital of Shangqiu

    collaborator UNKNOWN

  • Zhumadian Central Hospital

    collaborator OTHER

  • Anyang Regional Hospital

    collaborator OTHER

  • Luoyang Central Hospital

    collaborator OTHER

  • First People's Hospital of Kaifeng

    collaborator OTHER

  • Zhengzhou University

    lead OTHER

Principal Investigators

  • Liu Bingqian, Ph.D MD · The First Affiliated Hospital of Zhengzhou University

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614548 on ClinicalTrials.gov